iBio
IBIO
#10074
Rank
A$40.62 M
Marketcap
A$1.81
Share price
-6.25%
Change (1 day)
-55.01%
Change (1 year)

iBio (IBIO) - Net assets

Net assets on the balance sheet as of June 2025 : A$22.4 Million

According to iBio's latest financial reports the company has A$22.4 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

iBio - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$A$31.95 M38.44%
2023-06-30$A$23.07 M-74.92%
2022-06-30$A$92.03 M-36.44%
2021-06-30$A$0.14 B76.55%
2020-06-30$A$82.01 M2244.4%
2019-06-30$A$3.49 M-83.98%
2018-06-30$A$21.83 M88.04%
2017-06-30$A$11.61 M-64.03%
2016-06-30$A$32.27 M121.14%
2015-06-30$A$14.59 M125.68%
2014-06-30$A$6.46 M16.51%
2013-06-30$A$5.55 M-7.83%
2012-06-30$A$6.02 M3182.87%
2011-06-30$A$0.18 M-85.56%
2010-06-30$A$1.27 M-76.58%
2009-06-30$A$5.42 M-183.64%
2008-06-30$-A$6.49 Million26.73%
2007-06-30$-A$5.12 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Genocea Biosciences
GNCA
A$18.64 M-16.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.87 B 3,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B 532,675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.12 B 471.81%๐Ÿ‡บ๐Ÿ‡ธ USA